GlassScriptPhysician profile
Dikshya Sharma
NPI 1639581226
$294.08
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $243 · 2022: $51.54.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $112.00 | 2021 | |
| Janssen Pharmaceuticals, INC | $65.84 | 2021 | |
| Boston Scientific Corporation | $36.69 | 2022 | |
| Harmony Biosciences LLC | $18.28 | 2021 | |
| Jazz Pharmaceuticals INC. | $18.01 | 2021 | |
| Olympus America INC. | $14.85 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $14.51 | 2021 | |
| Paratek Pharmaceuticals, INC. | $13.90 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dikshya Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.